| scholarly article | Q13442814 |
| editorial | Q871232 |
| P356 | DOI | 10.3748/WJG.14.5617 |
| P8608 | Fatcat ID | release_dsf7pdqlgjevzcyi7cp7n4pxgu |
| P932 | PMC publication ID | 2748194 |
| P698 | PubMed publication ID | 18837076 |
| P5875 | ResearchGate publication ID | 23301572 |
| P2093 | author name string | Jose J G Marin | |
| P2860 | cites work | A gene encoding a liver-specific ABC transporter is mutated in progressive familial intrahepatic cholestasis | Q22004274 |
| Identification of a nuclear receptor for bile acids | Q22010058 | ||
| Bile acids: natural ligands for an orphan nuclear receptor | Q22010063 | ||
| A G protein-coupled receptor responsive to bile acids | Q24338558 | ||
| Hepatic secretion of conjugated drugs and endogenous substances | Q28143763 | ||
| The sodium bile salt cotransport family SLC10 | Q28186116 | ||
| Endogenous bile acids are ligands for the nuclear receptor FXR/BAR | Q28198990 | ||
| A multicenter, controlled trial of ursodiol for the treatment of primary biliary cirrhosis. UDCA-PBC Study Group | Q28243457 | ||
| The G-protein coupled bile salt receptor TGR5 is expressed in liver sinusoidal endothelial cells | Q28290420 | ||
| The superfamily of organic anion transporting polypeptides | Q33185578 | ||
| Elaboration of hepatocytic bile | Q33982695 | ||
| Bile Acid Metabolism | Q34008523 | ||
| Detergent Properties of Bile Salts: Correlation with Physiological Function | Q34231762 | ||
| Bile salt transporters | Q34516267 | ||
| Role of nuclear receptors in the adaptive response to bile acids and cholestasis: pathogenetic and therapeutic considerations. | Q34533943 | ||
| Endocrine functions of bile acids | Q34545426 | ||
| Nuclear receptor regulation of hepatic function | Q34666809 | ||
| Review: intrahepatic cholestasis. A puzzling disorder of pregnancy | Q34740078 | ||
| Bile acid regulation of gene expression: roles of nuclear hormone receptors. | Q34803254 | ||
| Coordinate transcriptional regulation of bile acid homeostasis and drug metabolism | Q35974423 | ||
| Evaluation of drug-drug interaction in the hepatobiliary and renal transport of drugs | Q36094600 | ||
| Molecular mechanisms of reduced glutathione transport: role of the MRP/CFTR/ABCC and OATP/SLC21A families of membrane proteins | Q36104164 | ||
| Drug transporters in pharmacokinetics | Q36419290 | ||
| Bile salt excretory pump: biology and pathobiology | Q36526802 | ||
| Hepatocellular sinusoidal membrane organic anion transport and transporters | Q36816494 | ||
| Bile acid transport systems as pharmaceutical targets | Q36829267 | ||
| Molecular pathogenesis of intrahepatic cholestasis of pregnancy. | Q37120978 | ||
| Bile salts and biliary lipids. | Q39698216 | ||
| Physiology of bile flow | Q39886594 | ||
| Secretion of bile acids by the liver and their role in the formation of hepatic bile | Q39918702 | ||
| Photochemical and biochemical basis of the treatment of neonatal jaundice | Q39930934 | ||
| The characteristics of mixed micellar solutions with particular reference to bile | Q39995937 | ||
| Hepatic Aspects of Bilirubin Metabolism | Q40034697 | ||
| Functional variants of the central bile acid sensor FXR identified in intrahepatic cholestasis of pregnancy | Q40097524 | ||
| New concepts of mechanisms of hepatocyte bile formation | Q40120419 | ||
| The effect of secretin and cholecystokinin-pancreozymin on the secretion of bile in the anaesthetized rabbit | Q40359381 | ||
| Activation of CREB by tauroursodeoxycholic acid protects cholangiocytes from apoptosis induced by mTOR inhibition | Q40429203 | ||
| Hepatobiliary secretion of organic compounds; molecular mechanisms of membrane transport | Q40462743 | ||
| Canalicular transport: discovery of ATP-dependent mechanisms | Q40708153 | ||
| Biliary excretion of xenobiotics | Q40717834 | ||
| Bilirubin conjugates: formation and detection | Q40754334 | ||
| Importance of solvent drag and diffusion in bile acid-dependent bile formation: ion substitution studies in isolated perfused rat liver | Q41624757 | ||
| Low in vivo toxicity of a novel cisplatin-ursodeoxycholic derivative (Bamet-UD2) with enhanced cytostatic activity versus liver tumors. | Q43610988 | ||
| Down-regulation of the Na+/taurocholate cotransporting polypeptide during pregnancy in the rat. | Q44290866 | ||
| Usefulness of liposomes loaded with cytostatic bile acid derivatives to circumvent chemotherapy resistance of enterohepatic tumors. | Q44329283 | ||
| Conjugated bile acids promote ERK1/2 and AKT activation via a pertussis toxin-sensitive mechanism in murine and human hepatocytes | Q44915348 | ||
| Tauroursodeoxycholic acid exerts anticholestatic effects by a cooperative cPKC alpha-/PKA-dependent mechanism in rat liver. | Q46516304 | ||
| Inborn errors of bile acid synthesis. | Q64930478 | ||
| Effect of bile acids on hepatic protoporphyrin metabolism in perfused rat liver | Q69398050 | ||
| Cholangiocyte biology | Q80112411 | ||
| P433 | issue | 37 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 5617-5619 | |
| P577 | publication date | 2008-10-01 | |
| P1433 | published in | World Journal of Gastroenterology | Q15708885 |
| P1476 | title | How we have learned about the complexity of physiology, pathobiology and pharmacology of bile acids and biliary secretion | |
| P478 | volume | 14 |
Search more.